Indian Pharma's Innovation Success in 2025

Indian pharmaceutical companies, long known for generics, saw their risky innovation bets yield major commercial success in 2025 through global deals and approvals. Discover the key players and what's next for 2026.

Karnal Pharma Park Delays Leave Drug Makers in Limbo

Pharmaceutical manufacturers in Haryana await land allocation for the Karnal Pharma Park, a project delayed since 2021. The park promises to boost drug production and exports. Read about the industry's demands and government's plans.

Page 420 of 887